Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT03695341

Completed

500mg Fulvestrant Versus Everolimus Plus Exemestane in MBC Patients Refractory to Previous AI

Breast Cancer
NCT03973034

Unknown

Clinical Application of ctDNA in Early Screening of Breast Cancer

Breast Cancer
NCT01663870

Unknown

Technology and Navigation to Improve Survivorship Care

Breast Cancer
NCT01597193

Completed

Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

Breast Cancer
NCT03939598

Unknown

Feasibility of Preoperative Tattooing of Percutaneously Biopsied Axillary Lymph Node: A Quasi Experimental Pilot Study

Breast Neoplasm
NCT02136927

Terminated

Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast Cancer

Breast Cancer
NCT02550210

Completed

A Study to Evaluate the Accuracy of a Breast Cancer Locator (BCL) in Patients With Palpable Cancers

Breast Cancer
NCT02384746

Terminated

Phase I Study of the Combination of MLN9708 and Fulvestrant (Millennium)

Breast Cancer
NCT02266602

Completed

Intraoperative Radiation Therapy in Early Stage Breast Cancer (IORTBreast)

Breast Cancer
NCT03556813

Completed

Artificial Intelligence vs Physicians for Breast Cancer Patients' Information

Breast Cancer
NCT02556684

Unknown

Breast-Specific Gamma Imaging and Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy (BSGILAB)

Breast Cancer
NCT02253459

Completed

Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer

Breast Cancer
NCT03907098

Unknown

Endostar in Combination With Chemotherapy in HER-2 Negative Advanced Breast Cancer

Breast Cancer
NCT01964391

Completed

A Study of Participant Satisfaction and Safety With Subcutaneously Administered Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer

Breast Cancer
NCT02666261

Completed

A Study on the Epidemiology and Testing of Human Epidermal Growth Factor-Receptor 2 (HER2) in Breast Cancer in Germany

Breast Cancer
NCT03385031

Completed

Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer Patients

Breast Cancer
NCT02897544

Completed

Integrative Approaches for Cancer Survivorship 2: Project 2 (IACS2)

Breast Cancer
NCT00107497

Completed

Radiation Therapy in Treating Women With Localized Breast Cancer (FAST)

Breast Cancer
NCT01881022

Completed

An Internet-based Psychosexual Intervention for Couples Following Treatment for Breast Cancer (IPSIC)

Breast Cancer
NCT03846999

Completed

Comorbidities and Health Care Services Utilisation Among Long-term Breast Cancer Survivors (SURBCAN)

Breast Cancer
NCT03829423

Unknown

An Enhanced Artificial Intelligence Breast MRI Interpretation System (IntelliScan)

Breast Cancer
NCT00320411

Completed

GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast Cancer

Neoplasms, Breast
NCT03624088

Completed

CBPR - BRCA Genetic Testing Among Orthodox Jews

Breast Cancer
NCT02544945

Completed

Comparing 3-D Printed vs Standard Bolus for Breast Cancer Chest Wall Radiotherapy

Breast Cancer
NCT00096369

Terminated

Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer

Breast Cancer
NCT01790932

Completed

BKM120 For Triple Negative Breast Cancer

Breast Cancer
NCT02010021

Completed

Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer.

Breast Cancer
NCT03789851

Unknown

Minimally Invasive Biopsy Predicting Breast pCR After NAC for Breast Cancer (MIBPBPCR)

Breast Cancer
NCT03647280

Unknown

The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer

Breast Cancer
NCT01879189

Completed

PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk

Breast Cancer
NCT01840163

Completed

A Trial of a Comprehensive Breast Cancer Treatment Patient Decision Tool

Breast Cancer
NCT00214149

Terminated

Multi-catheter High Dose Rate (HDR) Breast Brachytherapy

Breast Cancer
NCT00640861

Completed

Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer

Breast Cancer
NCT03710018

Unknown

Impact of Tumor Bed Localisation on Dosimetry Boost Irradiation in Patients Undergoing Breast Conserving Surgery

Breast Carcinoma
NCT00793962

Completed

A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer

Breast Cancer
NCT02734121

Completed

PEGI to Improve Shared Decision-Making for Breast Reconstruction (PEGI)

Breast Cancer
NCT02802748

Completed

Phase 0 Study of Metronomic Oral Vinorelbine and Letrozole in HR+/HER2-negative Early Breast Cancer Patients (VENTANA)

Breast Cancer
NCT01923168

Completed

Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women

Breast Cancer
NCT02028494

Unknown

Evaluation of Response to Two Schedules of Capecitabine in Patients With Metastatic Breast Cancer (CAP7/7)

Breast Cancer
NCT00462956

Completed

GW572016 In Patients With Advanced Or Metastatic Breast Cancer

Neoplasms, Breast
NCT00495209

Completed

Pre-Surgical Qigong Therapy for Women With Breast Cancer

Breast Cancer
NCT01190345

Completed

Anti Cancer Stem Cell Activity of Pre-operative Bevacizumab and Chemotherapy in Breast Cancer (AVASTEM)

Breast Cancer
NCT01690325

Terminated

Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON)

Breast Cancer
NCT00428922

Completed

Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients

Breast Cancer
NCT01485926

Completed

A Phase II Neo-adjuvant Study Assessing TCH (Docetaxel, Carboplatin and Trastuzumab) and TCHL (Docetaxel, Carboplatin, Trastuzumab and Lapatinib) in HER-2 Positive Breast Cancer Patients. (TCHL Phase II)

Breast Cancer
NCT00772824

Completed

Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients

Breast Cancer
NCT03587259

Unknown

Innovation in Mammography: Tomosynthesis Pathways (IMPETO)

Breast Cancer
NCT01937689

Completed

Study of Pyrotinib in Patients With Human Epidermalgrowth Factor Receptor 2 (HER2) Positive Advanced Breast Cancer

Breast Cancer
NCT03580837

Unknown

Breast MRI for Neaodjuvant Chemotherapy Response Prediction and Evaluation in Breast Cancer

Breast Cancer
NCT00687440

Completed

A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679)

Breast Neoplasm

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations